2008-December Archives by Subject
Starting: Mon Dec 1 10:28:03 2008
Ending: Tue Dec 23 08:31:16 2008
Messages: 97
- [Ip-health] "Round Table: Intellectual property in connection with access to
drugs: prospects for the future"
Salut per al desenvolupament
- [Ip-health] **ACTION: Reponse Letter to Smith-Kind re Thailand- Circulate Widely**]
AMSA JRLD
- [Ip-health] 2009 Nomin2009 Nomination Period Opens For ICANN Leadership Positions
Khaled KOUBAA
- [Ip-health] : Academic Patents & Access to Med - Sampat, AJPH Jan 2009
Jay Purcell
- [Ip-health] =?ISO-8859-1?Q?ICTSD:_La_OPS_ante_el_desaf=EDo_de_la_salud_p=FAb?=
=?ISO-8859-1?Q?lica,_la_innovaci=F3n_y_la_propiedad_intelectual?=
Judit Rius Sanjuan
- [Ip-health] \UC Berkeley: New $7 Million Pledge for neglected diseases
Temina Madon
- [Ip-health] AP: Biotech industry lobbying efforts
Sarah Rimmington
- [Ip-health] AP: Generic drug prices falling in US
Sarah Rimmington
- [Ip-health] Are tenders part of the HIF? And how do they compare to open
licensing?
james.love@keionline.org
- [Ip-health] Becerra refuses USTR appointment; the speculation
continues
Jeffrey A. Williams
- [Ip-health] Becerra refuses USTR appointment; the speculation continues
Sarah Rimmington
- [Ip-health] Big Pharma No Threat to Biotech...Yet
Sarah Rimmington
- [Ip-health] Biogenerics, Not Just Biosimilars
Sarah Rimmington
- [Ip-health] Biotech Transfer Week: US Government Must Take Steps to
StrengthenIndustry-Academia Ties, PCAST Report Says
Ethan Guillen
- [Ip-health] Brazilian local groups launch Campaign against Patent Abuse
Renata Reis
- [Ip-health] Brazilian local groups launch Campaign against Patent Abuse
Renata Reis
- [Ip-health] CL and HIF
Sean Flynn
- [Ip-health] COMBATING GLOBAL FINANCIAL CRISIS - NCEUS for Rs 58,000 cr bailout for the poor
Indian Society For Sustainable Agriculture
- [Ip-health] Compulsory Licensing
Aidan Hollis
- [Ip-health] Compulsory Licensing
james.love@keionline.org
- [Ip-health] Compulsory Licensing
Aidan Hollis
- [Ip-health] Compulsory Licensing
James Love
- [Ip-health] Copy of Madras High Court judgment setting aside valganiclovir patent
prathibha siva
- [Ip-health] Countries propose royalty free licenses & NO IP on biological
materials
Sangeeta
- [Ip-health] Critics Top Shortlist for FDA Head
Riaz K Tayob
- [Ip-health] Cross posting from e-drug (28 November 2008): Counterfeit medicines and WHO
Thiru Balasubramaniam
- [Ip-health] EGA press release on WHO IMPACT's definition of Counterfeit Medicines
Thiru Balasubramaniam
- [Ip-health] Email alert: December issue of the WHO Bulletin
bulletin
- [Ip-health] Ex-Dallas Mayor Kirk to be USTR; Labor worried about nomination
Sarah Rimmington
- [Ip-health] FT: Goldman unveils plans for pharma research funding
Judit Rius Sanjuan
- [Ip-health] FTC Alleges Price Gouging, Monopoly For Baby Medicines
James Love
- [Ip-health] GNNTD: Students Lead the Way, Raise Awareness and Funds for NTD Control Efforts
Matt Price
- [Ip-health] HAI Africa Kenya update: amended Anti-Counterfeit Bill to be passed into law
Christa Cepuch
- [Ip-health] HAI Europe Press release & Event Memo: Litigation instead of Innovation- European Commission's Pharma Competition Report
Terri - Louise Beswick
- [Ip-health] HIF and bid auctions
Sean Flynn
- [Ip-health] HIF and bid auctions
michael.davis@law.csuohio.edu
- [Ip-health] HIF proposes $600 million annual budget to
evaluate health impacts
michael.davis@law.csuohio.edu
- [Ip-health] HIF proposes $600 million annual budget to
evaluate health impacts
michael.davis@law.csuohio.edu
- [Ip-health] HIF proposes $600 million annual budget to
evaluate health impacts
michael.davis@law.csuohio.edu
- [Ip-health] HIF proposes $600 million annual budget to
evaluate health impacts
michael.davis@law.csuohio.edu
- [Ip-health] HIF proposes $600 million annual budget to evaluate
health impacts
robert weissman
- [Ip-health] HIF proposes $600 million annual budget to evaluate health impacts
Malini Aisola
- [Ip-health] HIF proposes $600 million annual budget to evaluate health impacts
Aidan Hollis
- [Ip-health] IAVI announces $150,000 challenge in search of new approaches to
AIDS vaccine design
Sarah Rimmington
- [Ip-health] INDIAN GOVERNMENT MAINTAINS ANTI-ACCESS POSITION REGARDING PUBLICLY-FUNDED RESEARCH
Anjali Dalal
- [Ip-health] Invitation to guest blog
annweil1@sbcglobal.net
- [Ip-health] Invitation: AAAS Science and Human Rights Coalition Launch, January
14-16, 2009
Mike
- [Ip-health] IP Watch: Last-Minute Progress Made On Pandemic Flu; More Still
To Come
Sangeeta
- [Ip-health] IP-Watch: Lamy Challenges Discontented WTO Members To Use TRIPS Public Health Review
Thiru Balasubramaniam
- [Ip-health] JAMA: Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease
Sam Houshower
- [Ip-health] KEI Comments to the Priority Review Voucher Mechanism
Malini Aisola
- [Ip-health] Key issues unresolved at WHO meeting on influenza virus sharing
Sangeeta
- [Ip-health] Madras High Court sets aside patent on valganciclovir
aidslaw@lawyerscollective.org
- [Ip-health] Merck Wants To Develop Follow-On Biologics
Sarah Rimmington
- [Ip-health] MSF Access Campaign Statement: VALGANCICLOVIR PATENT SET ASIDE IN INDIA
Alexandra HEUMBER
- [Ip-health] New US Trade Rep And Compulsory Licensing
Sarah Rimmington
- [Ip-health] New York Time editorial: (Generic) Drug Resistance
Thiru Balasubramaniam
- [Ip-health] New York Times: British Balance Gain Against the Cost of the Latest Drugs
Thiru Balasubramaniam
- [Ip-health] North-South fight on IP, Benefit Sharing issues in influenza talks
Sangeeta
- [Ip-health] NYT LTE re Biogenerics: Cost of Living: Who Gets New Drugs?
Sarah Rimmington
- [Ip-health] Obama transition - Economics and Trade
Malini Aisola
- [Ip-health] Ovation Pharma raises price of heart medicine 1300% after buying
sole competitor
Mike Palmedo
- [Ip-health] Pharma Anti-Counterfeiting Conference, 30th June-2nd July, London
chan park
- [Ip-health] Possible US Trade Rep. Becerra on IP & Health
Ben Krohmal
- [Ip-health] Re: [A2k] TWN INFO: WCO secretariat for disbanding SECURE Working Group
Jeffrey A. Williams
- [Ip-health] Re: Ip-health digest, Vol 1 #2752 - 20 msgs
Thomas Pogge
- [Ip-health] Re: Ip-health digest, Vol 1 #2752 - 20 msgs
James Love
- [Ip-health] Re: Ip-health digest, Vol 1 #2752 - 20 msgs
James Love
- [Ip-health] Re: Ip-health digest, Vol 1 #2752 - 20 msgs
michael.davis@law.csuohio.edu
- [Ip-health] Re: Ip-health digest, Vol 1 #2752 - 20 msgs
michael.davis@law.csuohio.edu
- [Ip-health] Rep. Becerra Offered Post of US Trade Representative
Mike Palmedo
- [Ip-health] Report: Becerra Chosen to Head USTR
Ben Krohmal
- [Ip-health] researcher
Thomas Pogge
- [Ip-health] researcher
Jon Merz
- [Ip-health] researcher
Jeffrey A. Williams
- [Ip-health] researcher
michael.davis@law.csuohio.edu
- [Ip-health] Reuters: Lilly eyes entry into biogenerics arena
Sarah Rimmington
- [Ip-health] Senator Recommends Pfizer Whistleblower Peter Rost As FDA Commish
Sarah Rimmington
- [Ip-health] Shipments seizure: India's drug makers may avoid EU route
Riaz K Tayob
- [Ip-health] Statement by India on virus benefit sharing
Sangeeta
- [Ip-health] TACD Conference on IP, 12-13 January 2009, Washington, DC
Anne-Catherine Lorrain
- [Ip-health] The chickens come home to roost (Virus sharing, IPR, and CBD
issues)
Sangeeta
- [Ip-health] The Economist: =?windows-1252?Q?Merck=92s_woes_illuminate_?=
=?windows-1252?Q?the_shifts_taking_place_in_the_drugs_indu?=
=?windows-1252?Q?stry?=
Sarah Rimmington
- [Ip-health] The Evidence Gap,Setting a Price on Life
Riaz K Tayob
- [Ip-health] The U.S. FDA Priority Review Voucher The right mechanism to develop drugs
for neglected diseases
=?UTF-8?B?4oCmb3IgY29ycG9yYXRlIHdlbGZhcmUgaW4gZGlzZ3Vpc2UgPw==?=
Leyla.POPE@geneva.msf.org
- [Ip-health] Times of India: HC revokes Roche's patent
James ARKINSTALL
- [Ip-health] TWN INFO: WCO secretariat for disbanding SECURE Working Group
Sangeeta
- [Ip-health] Unbranding Medicines
=?iso-8859-1?Q?=97_Harvard_workshop_on_generics_?=
james.love@keionline.org
- [Ip-health] Unbranding Medicines - Harvard workshop on generics
james.love@keionline.org
- [Ip-health] Wall Street Journal Health Blog: From Patent Thickets to Payoffs: How Big Pharma Fights Generics
Thiru Balasubramaniam
- [Ip-health] Wall Street Journal Health Policy: Glaxo Returns to Court in Fight Over Patent Procedures
Thiru Balasubramaniam
- [Ip-health] Wall Street Journal: Merck to Develop Biotech Generics
Thiru Balasubramaniam
- [Ip-health] Washington DC HIF meeting
Judit Rius Sanjuan
- [Ip-health] Washington DC HIF meeting
mko
- [Ip-health] WIPO (Save the Date, July 13-14, 2009): Conference on IP and Global Challenges
Thiru Balasubramaniam
- [Ip-health] WIPO's new DG features IP enforcement as a Strategic Goal
Sangeeta
- [Ip-health] WTO Director-General Pascal Lamy: Access to medicines has been improved
Thiru Balasubramaniam
Last message date:
Tue Dec 23 08:31:16 2008
Archived on: Tue Dec 23 08:31:17 2008
This archive was generated by
Pipermail 0.05 (Mailman edition).